Clinical Trials

Clinical trials should be every patient's starting point when it comes to pancreatic cancer. Find out about trials that are available today, and the cutting-edge research available to patients.

129 Articles

Abstract image of round and oval shapes in reds, pinks, whites, and light blues
Research
November 30, 2017 • 2 Min

Testing an Experimental Combination of Drugs

A clinical trial for some cancers including pancreatic cancer tests the effectiveness of a checkpoint inhibitor and an antisense oligonucleotide inhibitor.

Dr. Allyson Ocean
Research
November 7, 2017 • 4 Min

Standard of Care Plus

Dr. Allyson Ocean explains why pancreatic cancer patients should consider clinical trials, which go beyond standard of care.

Microscope slide of the pancreas, with the some structures in purple and some in pink
Research
August 30, 2017 • 2 Min

More Effective Focused Radiation Therapy and Chemotherapy for Locally Advanced Pancreatic Cancer

A clinical trial tests whether adding Zometa makes chemotherapy and stereotactic body radiation therapy (SBRT) more effective against pancreatic cancer.

Microscope image of pancreatic cells in purple and teal on a dark background
Research
April 18, 2017 • 2 Min

Testing a Signal-Inhibiting Drug on Tumors with Specific Mutations

A new drug for certain tumor mutations is being tested in a type of clinical trial called a basket trial, which matches tumor genetics and drugs.

Pancreas cross section embedded in paraffin wax, stained blue and purple, 100x magnification.
Research
January 16, 2017 • 2 Min

Comparing a Standard Chemotherapy With and Without a PARP Inhibitor

A clinical trial compares standard chemotherapy with and without the addition of a PARP inihibitor, for patients whose pancreatic cancer is spreading again.

glass laboratory pipettes
Research
December 6, 2016 • 4 Min

The First Line of Defense against Pancreatic Cancer

Drs. Allyson Ocean and David Tuveson explain why pancreatic cancer patients should participate in clinical trials at the time of diagnosis.

Cancer researcher Sunil Hingorani
Research
September 19, 2016 • 4 Min

New Drug Shows Positive Results in Early Trials

A new drug called PEGPH20, which helps chemotherapy drugs reach their target, is showing positive results in an ongoing pancreatic cancer trial.

Microscopy image of a tumor section (obtained from a mouse tumor model) shows the blue-stained nanoparticles selectively accumulating in the peripheral tumor area and then penetrating into tumor cells
Research
August 18, 2016 • 2 Min

Exploring the Effectiveness of an Experimental Class of Drug

Does adding a PARP inhibitor drug to standard treatment help control the spread of advanced pancreatic cancer in patients with the BRCA mutation?

Big blue gloves handling lab samples
Research
June 6, 2016 • 2 Min

Patients Needed for Clinical Trial/Research Study of Treatment Targeting Immune System

A clinical trial seeks pancreatic cancer patients with the MSI (microsatellite instability) genetic signature, to test an immunotherapy drug.